PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,164,919 | -5.3% | 67,181 | -1.0% | 0.00% | 0.0% |
| Q2 2023 | $1,229,659 | +13.2% | 67,862 | +66.1% | 0.00% | 0.0% |
| Q1 2023 | $1,086,690 | +102.4% | 40,853 | +42.6% | 0.00% | – |
| Q4 2022 | $536,987 | -9.1% | 28,643 | +0.7% | 0.00% | – |
| Q3 2022 | $590,497 | +645.5% | 28,440 | +151.7% | 0.00% | – |
| Q1 2022 | $79,213 | -56.5% | 11,300 | -16.3% | 0.00% | – |
| Q4 2021 | $182,000 | -16.5% | 13,497 | +4.4% | 0.00% | – |
| Q3 2021 | $218,000 | -45.1% | 12,934 | -5.1% | 0.00% | – |
| Q2 2021 | $397,000 | -24.4% | 13,626 | +2.1% | 0.00% | – |
| Q1 2021 | $525,000 | – | 13,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |